Cullen/Frost Bankers, Inc. United Therapeutics Corp Transaction History
Cullen/Frost Bankers, Inc.
- $7.23 Billion
- Q3 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 159 shares of UTHR stock, worth $57,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159Holding current value
$57,756% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
667Shares Held
42.7MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.99 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.6 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.15 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$813 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...